Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference15 articles.
1. Migraine CA (2017) N Engl J Med 377(17):1698–1699
2. Dodick DW (2019) CGRP ligand and receptor monoclonal antibodies for migraine prevention: evidence review and clinical implications. Cephalalgia 39(3):445–458
3. American Headache Society (2019) The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 59(1):1–18
4. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65–69
5. Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T et al (2014) A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia 34(7):523–532
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献